- Home
- REVB vs SGN Comparison
REVB vs SGN Comparison
Compare REVB & SGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REVB
- SGN
- Stock Information
- Founded
- REVB 2020
- SGN 2019
- Country
- REVB United States
- SGN United States
- Employees
- REVB N/A
- SGN N/A
- Industry
- REVB Biotechnology: Pharmaceutical Preparations
- SGN
- Sector
- REVB Health Care
- SGN
- Exchange
- REVB Nasdaq
- SGN Nasdaq
- Market Cap
- REVB 4.4M
- SGN 3.8M
- IPO Year
- REVB N/A
- SGN 2023
- Fundamental
- Price
- REVB $1.55
- SGN $1.94
- Analyst Decision
- REVB
- SGN
- Analyst Count
- REVB 0
- SGN 0
- Target Price
- REVB N/A
- SGN N/A
- AVG Volume (30 Days)
- REVB 890.8K
- SGN 193.4K
- Earning Date
- REVB 11-07-2025
- SGN 11-13-2025
- Dividend Yield
- REVB N/A
- SGN N/A
- EPS Growth
- REVB N/A
- SGN N/A
- EPS
- REVB N/A
- SGN N/A
- Revenue
- REVB N/A
- SGN $391,126.00
- Revenue This Year
- REVB N/A
- SGN N/A
- Revenue Next Year
- REVB N/A
- SGN N/A
- P/E Ratio
- REVB N/A
- SGN N/A
- Revenue Growth
- REVB N/A
- SGN N/A
- 52 Week Low
- REVB $1.50
- SGN $0.44
- 52 Week High
- REVB $60.48
- SGN $36.70
- Technical
- Relative Strength Index (RSI)
- REVB 25.99
- SGN 60.63
- Support Level
- REVB $1.50
- SGN $1.78
- Resistance Level
- REVB $2.90
- SGN $2.10
- Average True Range (ATR)
- REVB 0.20
- SGN 0.14
- MACD
- REVB -0.13
- SGN 0.03
- Stochastic Oscillator
- REVB 3.57
- SGN 74.60
About REVB Revelation Biosciences Inc.
Revelation Biosciences Inc is a clinical-stage life science company that is focused on rebalancing inflammation to optimize health using its proprietary formulation Gemini. It is developing a pipeline of potential high-value products based on Gemini. Gemini is Revelation's proprietary formulation of phosphorylated hexaacyl disaccharide (PHAD) an established TLR4 agonist that can stimulate the human body's innate immune response to prevent and treat disease. The product candidates are developed are based on Gemini formulation of PHAD. Gemini-based programs consist of: Gemini-SSI developed for the prevention of surgical site infection (SSI); Gemini-AKI developed for the prevention of acute kidney injury (AKI); and Gemini-CKD for the treatment of chronic kidney disease (CKD).
About SGN Signing Day Sports Inc.
Signing Day Sports Inc is a technology company developing and operating platforms aiming to allow significantly more student-athletes to go to college and continue playing sports. Its platform Signing Day Sports is a digital ecosystem to help athletes get discovered and recruited by coaches and recruiters across the country. It currently fully supports football and baseball, and it plans to expand the Signing Day Sports platform to include additional sports.